Back to UBS Group AG UBS Group AG

PHIOPHIO
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in PHIO PHARMACEUTICALS CORP

UBS Group AG holds 5,387 shares of PHIO (PHIO PHARMACEUTICALS CORP), worth $5,522 as of 2026-Q2. The position was decreased (-80.0% shares).

Current Value

$5,522

Current Shares

5,387

Total Value Change

-$291

Total Shares Change

+3,702

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5,387
-80.0%
$5,5220.0%$1.03
0
2026-Q1
Increased
26,987
+214.0%
$32,9250.0%$1.01
22
2025-Q4
Increased
8,594
+660x
$9,0240.0%$1.02
18
2025-Q3
New
13
-
$320.0%$2.36
17
2025-Q2
Exited
0
-100.0%
$00.0%$2.17
0
2025-Q1
Decreased
103
-95.7%
$1340.0%$1.29
0
2024-Q4
Increased
2,397
+42.3%
$4,3150.0%$1.90
13
2024-Q3
New
1,685
-
$5,8130.0%$3.50
24

Other major holders of PHIO: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used